找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Cancer Research and Treatment; Innovative Concepts Ouissam Al Jarroudi,Khalid El Bairi,Giuseppe Curig Book 2023 The Editor(s) (if ap

[復(fù)制鏈接]
樓主: Corrugate
11#
發(fā)表于 2025-3-23 11:24:24 | 只看該作者
https://doi.org/10.1007/978-981-15-9158-7caloric intake. While obesity and elevated body mass index are well-reported critical risk factors of BC occurrence, there is an expanding area of oncology assessing the impact of caloric intake and nutritional patterns in patients with cancer. Caloric restriction and fast mimicking alimentary regim
12#
發(fā)表于 2025-3-23 16:22:26 | 只看該作者
https://doi.org/10.1007/978-981-15-9158-7 standard treatment for HR?+?BC. Most patients, however, eventually develop resistance to ET, which limits their effectiveness and poses a major challenge for the management of HR?+?BC. Several mechanisms that contribute to ET resistance have been described. One of the most common mechanisms is the
13#
發(fā)表于 2025-3-23 21:01:26 | 只看該作者
14#
發(fā)表于 2025-3-23 23:45:12 | 只看該作者
https://doi.org/10.1007/978-981-15-9158-7surgical and radiotherapy techniques improve local control and symptom management, BM remains associated with a poor prognosis. In addition, the efficacy of currently approved systemic therapies in central nervous system (CNS) compartment is still limited, especially after progression on local thera
15#
發(fā)表于 2025-3-24 03:15:50 | 只看該作者
https://doi.org/10.1007/978-981-15-9158-7ent of breast cancer (BC) has increased the numbers of cancer survivors but with the risk of cardiovascular adverse events (CV-AEs). All drugs can potentially damage the cardiovascular system, with different types of clinical manifestations from ischemic myocardial disease to vasculitis, thrombosis
16#
發(fā)表于 2025-3-24 07:24:11 | 只看該作者
Recent Results in Cancer Researchatients. The applications of gene sequencing, including next-generation gene sequencing (NGS), have led to numerous questions on how to validate, implement, interpret, prioritize and operationalize precision medicine tools to deliver meaningful and impactful interventions. Limited benefit has been p
17#
發(fā)表于 2025-3-24 11:49:54 | 只看該作者
18#
發(fā)表于 2025-3-24 14:59:23 | 只看該作者
19#
發(fā)表于 2025-3-24 20:24:31 | 只看該作者
20#
發(fā)表于 2025-3-25 03:15:16 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 12:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
淮南市| 南郑县| 阿鲁科尔沁旗| 新巴尔虎左旗| 根河市| 江永县| 环江| 舟山市| 博罗县| 兴海县| 华蓥市| 德兴市| 丹凤县| 新乡市| 娄烦县| 仲巴县| 苏州市| 富川| 玉环县| 垫江县| 松原市| 黔东| 临朐县| 泽普县| 福建省| 德钦县| 民和| 五常市| 曲松县| 临漳县| 宁明县| 迭部县| 蛟河市| 乳山市| 巫溪县| 桃江县| 德钦县| 区。| 白水县| 酒泉市| 温泉县|